You have read all your free articles, to continue reading subscribe to read the rest of this content.
Charlotte Gummeson has been appointed new CEO of the Sahlgrenska Science Park in Gothenburg, Sweden. She will start her new position on the 1st of January 2016 and leaves behind her a position at Almi Invest, as Investment Manager. She has also worked as Investment Manager at Innovationsbron and Already…
Paul Hargreaves has been appointed Chief Development Officer (CDO), starting September 13. He will join the management team and have a key role in the clinical development of the company's project portfolio. The appointment of Hargreaves as CDO marks an important step for Spago Nanomedical as Already a subscriber Login…
AroCell has announced that Cecilia Ahlin joins the management team as Chief Medical Officer. Cecilia Ahlin will lead and develop AroCell’s clinical strategy with focus on getting more clinical evidence for the use of TK1 as a biomarker in cancer treatment. Still an active oncologist treating pAlready a subscriber Login…
Oasmia Pharmaceutical has announced the appointments of Kia Bengtsson as Head of Clinical Development and Johanna Röstin as Head of Regulatory Affairs with effect from October 1, 2021. The appointments strengthen Oasmia’s internal drug development expertise as the company progresses its portfoAlready a subscriber Login You have read all your…
